Your browser doesn't support javascript.
loading
PET Imaging of Sphingosine-1-Phosphate Receptor 1 with [18F]TZ4877 in Nonhuman Primates.
Gu, Jiwei; Zheng, Ming-Qiang; Holden, Daniel; Fowles, Krista; Qiu, Lin; Felchner, Zachary; Zhang, Li; Ropchan, Jim; Gropler, Robert J; Carson, Richard E; Tu, Zhude; Huang, Yiyun; Hillmer, Ansel T.
Affiliation
  • Gu J; Yale University.
  • Zheng MQ; Yale University.
  • Holden D; Yale University.
  • Fowles K; Yale University.
  • Qiu L; Washington University School of Medicine in Saint Louis: Washington University in St Louis School of Medicine.
  • Felchner Z; Yale University.
  • Zhang L; Yale University.
  • Ropchan J; Yale University.
  • Gropler RJ; Washington University School of Medicine in Saint Louis: Washington University in St Louis School of Medicine.
  • Carson RE; Yale University.
  • Tu Z; Washington University School of Medicine in Saint Louis: Washington University in St Louis School of Medicine.
  • Huang Y; Yale University.
  • Hillmer AT; Yale University.
Res Sq ; 2024 May 30.
Article in En | MEDLINE | ID: mdl-38854065
ABSTRACT

Purpose:

The sphingosine-1-phosphate receptor-1 (S1PR1) is involved in regulating responses to neuroimmune stimuli. There is a need for S1PR1-specific radioligands with clinically suitable brain pharmcokinetic properties to complement existing radiotracers. This work evaluated a promising S1PR1 radiotracer, [18F]TZ4877, in nonhuman primates. Procedures [18F]TZ4877 was produced via nucleophilic substitution of tosylate precursor with K[18F]/F- followed by deprotection. Brain PET imaging data were acquired with a Focus220 scanner in two Macaca mulatta (6, 13 years old) for 120-180 min following bolus injection of 118-163 MBq [18F]TZ4877, with arterial blood sampling and metabolite analysis to measure the parent input function and plasma free fraction (f P). Each animal was scanned at baseline, 15-18 min after 0.047-0.063 mg/kg of the S1PR1 inhibitor ponesimod, 33 min after 0.4-0.8 mg/kg of the S1PR1-specific compound TZ82112, and 167-195 min after 1 ng/kg of the immune stimulus endotoxin. Kinetic analysis with metabolite-corrected input function was performed to estimate the free fraction corrected total distribution volume (V T/f P). Whole-body dosimetry scans were acquired in 2 animals (1M, 1F) with a Biograph Vision PET/CT System, and absorbed radiation dose estimates were calculated with OLINDA.

Results:

[18F]TZ4877 exhibited fast kinetics that were described by the reversible 2-tissue compartment model. Baseline [18F]TZ4877 f P was low (< 1%), and [18F]TZ4877 V T/f P values were 233-866 mL/cm3. TZ82112 dose-dependently reduced [18F]TZ4877 V T/f P, while ponesimod and endotoxin exhibited negligible effects on V T/f P, possibly due to scan timing relative to dosing. Dosimetry studies identified the critical organs of gallbladder (0.42 (M) and 0.31 (F) mSv/MBq) for anesthetized nonhuman primate.

Conclusions:

[18F]TZ4877 exhibits reversible kinetic properties, but the low f P value limits quantification with this radiotracer. S1PR1 is a compelling PET imaging target, and these data support pursuing alternative F-18 labeled radiotracers for potential future human studies.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Res Sq Year: 2024 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Res Sq Year: 2024 Document type: Article Country of publication: United States